Advertisement
Screener

LIFECORE BIOMEDICAL, INC. (LFCR) Increase (Decrease) in Accrued Liabilities

2.8 / 5 stars · 68/120 Roast Me

LIFECORE BIOMEDICAL, INC. Increase (Decrease) in Accrued Liabilities

LIFECORE BIOMEDICAL, INC. (LFCR) reported Increase (Decrease) in Accrued Liabilities of $1.50 million for the 9-month period ending 2020-02-23, per its 10-Q filed 2020-04-03.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2020-04-03

  • LIFECORE BIOMEDICAL, INC. increase (decrease) in accrued liabilities for the quarter ending 2020-02-23 was $359.00K.
  • LIFECORE BIOMEDICAL, INC. increase (decrease) in accrued liabilities for the quarter ending 2019-11-24 was $2.04M, a 71.40% increase year-over-year.
  • LIFECORE BIOMEDICAL, INC. increase (decrease) in accrued liabilities for the quarter ending 2019-08-25 was -$893.00K, a 331.35% decline year-over-year.
  • LIFECORE BIOMEDICAL, INC. increase (decrease) in accrued liabilities for the quarter ending 2019-05-26 was -$734.00K.
  • LIFECORE BIOMEDICAL, INC. increase (decrease) in accrued liabilities for fiscal 2019 was $21.00K.
  • LIFECORE BIOMEDICAL, INC. increase (decrease) in accrued liabilities for fiscal 2018 was -$1.38M, a 166.30% decline from fiscal 2017.
  • LIFECORE BIOMEDICAL, INC. increase (decrease) in accrued liabilities for fiscal 2017 was $2.09M, a 18.39% decline from fiscal 2016.
  • LIFECORE BIOMEDICAL, INC. increase (decrease) in accrued liabilities for fiscal 2016 was $2.56M, a 23136.36% increase from fiscal 2015.
Period endIncrease (Decrease) in Accrued Liabilities 3 monthIncrease (Decrease) in Accrued Liabilities 3 month as first filedIncrease (Decrease) in Accrued Liabilities 6 monthIncrease (Decrease) in Accrued Liabilities 6 month as first filedIncrease (Decrease) in Accrued Liabilities 9 monthIncrease (Decrease) in Accrued Liabilities 9 month as first filedIncrease (Decrease) in Accrued Liabilities 12 monthIncrease (Decrease) in Accrued Liabilities 12 month as first filed
2020-02-23$359.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-04-03
$2.40M
derived: sum of 2 quarters · filed 2020-04-03
$1.50M
10-Q · filed 2020-04-03
$770.00K
derived: sum of 4 quarters · filed 2020-04-03
2019-11-24$2.04M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-01-02
$1.15M
10-Q · filed 2020-01-02
$411.00K
derived: sum of 3 quarters · filed 2020-01-02
-$409.00K
derived: sum of 4 quarters · filed 2020-04-03
2019-08-25-$893.00K
10-Q · filed 2019-10-03
-$1.63M
derived: sum of 2 quarters · filed 2019-10-03
-$2.45M
derived: sum of 3 quarters · filed 2020-04-03
-$1.26M
derived: sum of 4 quarters · filed 2020-04-03
2019-05-26-$734.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-01
-$1.55M
derived: sum of 2 quarters · filed 2020-04-03
-$365.00K
derived: sum of 3 quarters · filed 2020-04-03
$21.00K
10-K · filed 2019-08-01
2019-02-24-$820.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-04-03
$369.00K
derived: sum of 2 quarters · filed 2020-04-03
$755.00K
10-Q · filed 2020-04-03
-$179.00K
derived: sum of 4 quarters · filed 2020-04-03
2018-11-25$1.19M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-01-02
$1.57M
10-Q · filed 2020-01-02
$641.00K
derived: sum of 3 quarters · filed 2020-01-02
$2.46M
derived: sum of 4 quarters · filed 2020-01-02
2018-08-26$386.00K
10-Q · filed 2019-10-03
-$548.00K
derived: sum of 2 quarters · filed 2019-10-03
$1.27M
derived: sum of 3 quarters · filed 2019-10-03
-$728.00K
derived: sum of 4 quarters · filed 2019-10-03
2018-05-27-$934.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-01
$889.00K
derived: sum of 2 quarters · filed 2019-08-01
-$1.11M
derived: sum of 3 quarters · filed 2019-08-01
-$1.38M
10-K · filed 2019-08-01
2018-02-25$1.82M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-04-04
-$180.00K
derived: sum of 2 quarters · filed 2019-04-04
-$449.00K
10-Q · filed 2019-04-04
-$1.78M
derived: sum of 4 quarters · filed 2019-08-01
2017-11-26-$2.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-01-07
-$2.27M
10-Q · filed 2019-01-07
-$3.60M
derived: sum of 3 quarters · filed 2019-08-01
-$988.00K
derived: sum of 4 quarters · filed 2019-08-01
2017-08-27-$269.00K
10-Q · filed 2018-10-05
-$1.60M
derived: sum of 2 quarters · filed 2019-08-01
$1.01M
derived: sum of 3 quarters · filed 2019-08-01
$205.00K
derived: sum of 4 quarters · filed 2019-08-01
2017-05-28-$1.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-01
$1.28M
derived: sum of 2 quarters · filed 2019-08-01
$474.00K
derived: sum of 3 quarters · filed 2019-08-01
$2.09M
10-K · filed 2019-08-01
2017-02-26$2.62M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-04-05
$1.81M
derived: sum of 2 quarters · filed 2018-04-05
$3.42M
10-Q · filed 2018-04-05
$3.82M
derived: sum of 4 quarters · filed 2018-08-09
2016-11-27-$810.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-05
$802.00K
10-Q · filed 2018-01-05
$1.20M
derived: sum of 3 quarters · filed 2018-08-09
$2.19M
derived: sum of 4 quarters · filed 2018-08-09
2016-08-28$1.61M
10-Q · filed 2017-09-28
$2.01M
derived: sum of 2 quarters · filed 2018-08-09
$3.00M
derived: sum of 3 quarters · filed 2018-08-09
$4.59M
derived: sum of 4 quarters · filed 2018-08-09
2016-05-29$398.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-09
$1.38M
derived: sum of 2 quarters · filed 2018-08-09
$2.98M
derived: sum of 3 quarters · filed 2018-08-09
$2.56M
10-K · filed 2018-08-09
2016-02-28$986.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-04-07
$2.58M
derived: sum of 2 quarters · filed 2017-04-07
$2.16M
10-Q · filed 2017-04-07
$3.31M
10-Q · filed 2016-03-30
$2.58M
derived: sum of 4 quarters · filed 2018-03-15
2015-11-29$1.59M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-01-05
$1.17M
10-Q · filed 2017-01-05
$1.87M
10-Q · filed 2016-01-07
$1.60M
derived: sum of 3 quarters · filed 2018-03-15
$1.49M
derived: sum of 4 quarters · filed 2018-03-15
2015-08-30-$419.00K
10-Q · filed 2016-09-29
$706.00K
10-Q · filed 2015-10-01
$7.00K
derived: sum of 2 quarters · filed 2018-03-15
-$105.00K
derived: sum of 3 quarters · filed 2018-03-15
$676.00K
derived: sum of 4 quarters · filed 2018-03-15
2015-05-31$426.00K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-03-15
$314.00K
derived: sum of 2 quarters · filed 2018-03-15
$1.09M
derived: sum of 3 quarters · filed 2018-03-15
$11.00K
10-K/A · filed 2018-03-15
-$1.22M
10-K · filed 2015-07-31
2015-03-01-$112.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-30
$669.00K
derived: sum of 2 quarters · filed 2016-03-30
-$415.00K
10-Q · filed 2016-03-30
$255.00K
derived: sum of 4 quarters · filed 2016-08-01
2014-11-30$781.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-01-07
-$303.00K
10-Q · filed 2016-01-07
$367.00K
derived: sum of 3 quarters · filed 2016-08-01
$456.00K
derived: sum of 4 quarters · filed 2016-08-01
2014-08-31-$1.08M
10-Q · filed 2015-10-01
-$414.00K
derived: sum of 2 quarters · filed 2016-08-01
-$325.00K
derived: sum of 3 quarters · filed 2016-08-01
$1.13M
derived: sum of 4 quarters · filed 2016-08-01
2014-05-25$670.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-01
$759.00K
derived: sum of 2 quarters · filed 2016-08-01
$2.22M
derived: sum of 3 quarters · filed 2016-08-01
$3.21M
10-K · filed 2016-08-01
2014-02-23$89.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-02
$1.55M
derived: sum of 2 quarters · filed 2015-04-02
$2.54M
10-Q · filed 2015-04-02
$2.62M
derived: sum of 4 quarters · filed 2015-07-31
2013-11-24$1.46M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-01-09
$2.45M
10-Q · filed 2015-01-09
$2.53M
derived: sum of 3 quarters · filed 2015-07-31
$582.00K
derived: sum of 4 quarters · filed 2015-07-31
2013-08-25$993.00K
10-Q · filed 2014-10-08
$1.07M
derived: sum of 2 quarters · filed 2015-07-31
-$877.00K
derived: sum of 3 quarters · filed 2015-07-31
-$58.00K
derived: sum of 4 quarters · filed 2015-07-31
2013-05-26$78.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-31
-$1.87M
derived: sum of 2 quarters · filed 2015-07-31
-$1.05M
derived: sum of 3 quarters · filed 2015-07-31
-$2.49M
10-K · filed 2015-07-31
2013-02-24-$1.95M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-28
-$1.13M
derived: sum of 2 quarters · filed 2014-03-28
-$2.56M
10-Q · filed 2014-03-28
$1.56M
derived: sum of 4 quarters · filed 2014-08-01
2012-11-25$819.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-03
-$616.00K
10-Q · filed 2014-01-03
$3.51M
derived: sum of 3 quarters · filed 2014-08-01
$2.90M
derived: sum of 4 quarters · filed 2014-08-01
2012-08-26-$1.44M
10-Q · filed 2013-09-26
$2.69M
derived: sum of 2 quarters · filed 2014-08-01
$2.08M
derived: sum of 3 quarters · filed 2014-08-01
$1.72M
derived: sum of 4 quarters · filed 2014-08-01
2012-05-27$4.13M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-01
$3.52M
derived: sum of 2 quarters · filed 2014-08-01
$3.16M
derived: sum of 3 quarters · filed 2014-08-01
$3.43M
10-K · filed 2014-08-01
2012-02-26-$607.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-04-04
-$967.00K
derived: sum of 2 quarters · filed 2013-04-04
-$691.00K
10-Q · filed 2013-04-04
-$595.00K
derived: sum of 4 quarters · filed 2013-08-07
2011-11-27-$360.00K
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-01-04
-$84.00K
10-Q · filed 2013-01-04
$12.00K
derived: sum of 3 quarters · filed 2013-08-07
2011-08-28$276.00K
10-Q/A · filed 2013-01-02
$372.00K
derived: sum of 2 quarters · filed 2013-08-07
2011-05-29$96.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-07
$532.00K
10-K · filed 2013-08-07
2011-02-27$436.00K
10-Q · filed 2012-03-28
2010-11-28-$16.00K
10-Q · filed 2012-01-05
2010-08-29$104.00K
10-Q · filed 2011-10-05
2010-05-30$703.00K
10-K · filed 2012-08-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
ADC Therapeutics SA (ADCT)$0.163B-1.39
Minerva Neurosciences, Inc. (NERV)United States$0.165B-0.66
Tonix Pharmaceuticals Holding Corp. (TNXP)United States$0.166B-1.34
Annexon, Inc. (ANNX)United States$0.147B-4.22
Corbus Pharmaceuticals Holdings, Inc. (CRBP)United States$0.144B-1.72
Organogenesis Holdings Inc. (ORGO)United States$0.182B-3.70
SPRUCE BIOSCIENCES, INC. (SPRB)United States$0.142B-2.89
Korro Bio, Inc. (KRRO)United States$0.141B-1.81
AN2 Therapeutics, Inc. (ANTX)United States$0.185B-4.84
Atrium Therapeutics, Inc. (RNA)United States$0.140B